Myovant Sciences Ltd. (MYOV)
(Delayed Data from NYSE)
$17.72 USD
+0.07 (0.40%)
Updated May 3, 2019 04:01 PM ET
After-Market: $17.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MYOV 17.72 +0.07(0.40%)
Will MYOV be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for MYOV based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MYOV
Myovant Sciences (MYOV) Reports Q3 Loss, Lags Revenue Estimates
Myovant Sciences (MYOV) Reports Q2 Loss, Tops Revenue Estimates
MYOV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Tango Therapeutics, Inc. (TNGX) Stock Jumps 16.3%: Will It Continue to Soar?
Myovant Sciences (MYOV) Reports Q1 Loss, Tops Revenue Estimates